fbpx
  Previous   Next
HomeHealthPfizer's Omicron Vaccine Will Be Ready In March

Pfizer’s Omicron Vaccine Will Be Ready In March

Pfizer CEO Albert Bourla said a vaccine that targets the omicron variant of Covid will be ready in March, and the company’s already begun manufacturing the doses.

“This vaccine will be ready in March,” Bourla told CNBC’s “Squawk Box.” “We already starting manufacturing some of these quantities at risk.”

Bourla said the vaccine will also target the other variants that are circulating. He said it is still not clear whether or not an omicron vaccine is needed or how it would be used, but Pfizer will have some doses ready since some countries want it ready as soon as possible.

“The hope is that we will achieve something that will have way, way better protection particularly against infections, because the protection against the hospitalizations and the severe disease it is reasonable right now, with the current vaccines as long as you are having let’s say the third dose,” Bourla said.

Real-world data from the United Kingdom has shown that Pfizer’s and Moderna’s vaccines are only about 10% effective at preventing symptomatic infection from omicron 20 weeks after the second dose, according to study from the U.K. Health Security Agency.

However, the original two doses still provide good protection against severe illness, the study found.

Booster shots are up to 75% effective at preventing symptomatic infection, according to the study.

White House chief medical advisor Dr. Anthony Fauci said in December that there is no need for a booster shot that specifically targets omicron, because the current boosters work well against the variant.

Moderna CEO Stephane Bancel told the company is working on a booster for this fall that targets omicron and it will enter clinical trials soon. Bancel said demand is high from governments as they prepare regular vaccination against the virus.

Bourla said it’s not clear whether a fourth dose is needed. He said Pfizer will conduct experiments to determine if another dose is necessary.

Israel has made a fourth dose of Pfizer and BioNTech’s vaccine available to people over the age of 60, people with compromised immune systems and health-care workers.

Israel found that a fourth dose of the vaccine increases antibodies that protect against the virus fivefold a week after receiving the shot.

More News

Coronavirus: India Reports 14,506 New Covid Cases

India logged 14,506 new coronavirus cases in the last 24 hours, taking the total number of COVID-19 cases to 4,34,33,345. According to the Union...

Russian Prez Is Getting ‘Exactly What He Didn’t Want’: US Prez

US President Joe Biden on Wednesday said Russian President Vladimir Putin is getting ‘exactly what he didn’t want’ the NATO-nation of Europe, the media...

28% GST On Casinos, Online Gaming, Horse Racing And Lottery Has Been Deferred: FM

The two-day GST council meeting, headed by Union Finance Minister Nirmala Sitharaman, in Chandigarh concluded on Wednesday. After the meeting, FM Sitharaman announced that...

RELATED NEWS

Coronavirus: India Reports 11,793 New Covid- 19 Cases In Last 24 Hours

India has reported 11,793 new covid- 19 cases in last 24 hours with the number of active cases constituting 0.22% of the total number...

Coronavirus: India Reports 17,073 New Covid Cases

India reported 17,073 fresh Covid-19 cases and 21 deaths in the 24 hours ending at 8 am on Monday. The new cases marked a...

World Health Network Declares Monkeypox A Pandemic, 3,417 Cases Reports Across 58 Countries

3,417 confirmed Monkeypox cases reported across 58 countries, World Health Network (WHN) has announced that they are declaring the current monkeypox outbreak a pandemic. The...